CLVRX Mutual Fund

NAV$42.03

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.19%
Dividend Yield (Current)
7.69%
Holdings
548
Inception Date
Feb 1, 2022
Fund Family
Calvert
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+21.40%
1 Year+31.90%
3 Year+20.11%

Asset Allocation

Stocks: 99.83%
Cash: 0.17%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
JPMJpmorgan Chase3.46%
BAC.KBank Of America Corp2.02%
MRKMerck & Company Inc1.74%
WFCWells Fargo & Co.1.47%
UNHUnitedhealth Group, Inc.1.46%
Top 10 Concentration: 16.66%Report Date: Mar 31, 2026
Download all 548 holdings for CLVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.69%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

CLVRX Mutual Fund Overview

CLVRX Mutual Fund (Calvert US Large Cap Value Responsible Index Fund Class R6) is managed by Calvert. CLVRX expense ratio is 0.19%, holding 548 positions across sectors including Financials, Health Care, Unknown. Inception date: 2022-02-01.

CLVRX performance shows a YTD return of 21.40%. The 1-year return is 31.90%. CLVRX dividend yield stands at 7.69%, paid annually.

CLVRX top holdings include Jpmorgan Chase (3.5%), Bank Of America Corp (2.0%), Merck & Company Inc (1.7%), Wells Fargo & Co. (1.5%), Unitedhealth Group, Inc. (1.5%). View all CLVRX holdings, sector breakdown, or dividend history.

CLVRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CLVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.